European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
出版年份 2021 全文链接
标题
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
作者
关键词
-
出版物
CLINICAL MICROBIOLOGY AND INFECTION
Volume 27, Issue -, Pages S1-S21
出版商
Elsevier BV
发表日期
2021-10-22
DOI
10.1016/j.cmi.2021.09.038
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Management of Severe and Severe/Complicated Clostridoides difficile Infection using Sequential Fecal Microbiota Transplant by Retention Enema
- (2021) Abbas Hatim Rupawala et al. CLINICAL INFECTIOUS DISEASES
- Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: A systematic review & meta-analysis
- (2021) Kristin M. D’Silva et al. CLINICAL MICROBIOLOGY AND INFECTION
- Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study
- (2021) Bojana Milenković et al. European Journal of Hospital Pharmacy-Science and Practice
- Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection
- (2021) Jiahe Chen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review
- (2021) Tessel M. van Rossen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence
- (2020) Konstantinos S. Kechagias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients
- (2020) Ryan Miller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Heart Failure Is a Risk Factor for Suffering and Dying of Clostridium difficile Infection. Results of a 15-Year Nationwide Study in Spain
- (2020) Manuel Méndez-Bailón et al. Journal of Clinical Medicine
- Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection
- (2020) Travis J Carlson et al. Open Forum Infectious Diseases
- Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non‐Fulminant Severe Clostridioides difficile Infection
- (2020) Ana D. Vega et al. PHARMACOTHERAPY
- Clostridioides difficile ribotype distribution in a large teaching hospital in Serbia
- (2020) Miloš Korać et al. Gut Pathogens
- Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study
- (2020) Richard L Hengel et al. Open Forum Infectious Diseases
- The effect of Saccharomyces boulardii primary prevention on risk of Hospital Onset Clostridioides difficile infection in hospitalized patients administered antibiotics frequently associated with Clostridioides difficile infection
- (2020) Eric Wombwell et al. CLINICAL INFECTIOUS DISEASES
- Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
- (2020) Gianluca Ianiro et al. GUT
- Oral vancomycin prophylaxis against recurrent Clostridioides difficile infection: Efficacy and side effects in two hospitals
- (2020) Ioannis M. Zacharioudakis et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Renal Impairment, C. difficile Recurrence, and the Differential Effect of Bezlotoxumab: A Post Hoc Analysis of Pooled Data From 2 Randomized Clinical Trials
- (2020) Yoav Golan et al. Open Forum Infectious Diseases
- Changes in the Association between Diagnostic Testing Method, PCR Ribotype, and Clinical Outcomes from Clostridioides difficile Infection: One Institution’s Experience
- (2020) Anitha Menon et al. CLINICAL INFECTIOUS DISEASES
- Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry
- (2020) Colleen R. Kelly et al. GASTROENTEROLOGY
- Clinical significance of a positive Clostridioides difficile glutamate dehydrogenase test on the outcomes of hospitalized older patients
- (2020) Yohsuke Nagayoshi et al. Geriatrics & Gerontology International
- The significance of acute kidney injury in Clostridioides difficile infection
- (2020) T Avni et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Risk of complications and mortality following recurrent and non-recurrent Clostridioides difficile infection: a retrospective, observational, database study in England
- (2020) David A. Enoch et al. JOURNAL OF HOSPITAL INFECTION
- Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
- (2020) Guy de Bruyn et al. LANCET INFECTIOUS DISEASES
- Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank
- (2020) Elisabeth M Terveer et al. United European Gastroenterology Journal
- Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
- (2020) Rosa Escudero-Sánchez et al. Journal of Clinical Medicine
- Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection
- (2019) Christian Lodberg Hvas et al. GASTROENTEROLOGY
- Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials
- (2019) Dale N Gerding et al. LANCET INFECTIOUS DISEASES
- Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial
- (2019) John F Kokai-Kun et al. LANCET INFECTIOUS DISEASES
- Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings
- (2019) Haley J Appaneal et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Extended-pulsed fidaxomicin versus vancomycin in patients 60 years and older with Clostridium difficile infection: cost-effectiveness analysis in Spain
- (2019) Carlos Rubio-Terrés et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Oral vancomycin prophylaxis during systemic antibiotic exposure to prevent Clostridiodes difficile infection relapses
- (2019) Daniel A. Caroff et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Vancomycin Prophylaxis for Clostridium difficile Infection among Lung Transplant Recipients
- (2019) Valida Bajrovic et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Predictors of mortality and length of stay in patients with hospital-acquired Clostridioides difficile infection: a population-based study in Alberta, Canada
- (2019) J. Leal et al. JOURNAL OF HOSPITAL INFECTION
- Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset
- (2019) Tomomi Kimura et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population
- (2019) Taylor Morrisette et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland
- (2019) Jarmo Oksi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A possible association between statin use and improved Clostridioides difficile infection mortality in veterans
- (2019) Jacqueline R. Argamany et al. PLoS One
- Trends in Diverting Loop Ileostomy vs Total Abdominal Colectomy as Surgical Management for Clostridium Difficile Colitis
- (2019) Yen-Yi Juo et al. JAMA Surgery
- Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure
- (2019) Steven W Johnson et al. CLINICAL INFECTIOUS DISEASES
- Correlation between tcdB gene PCR cycle threshold and severe Clostridium difficile disease
- (2019) M.A. De Francesco et al. ANAEROBE
- Does oral vancomycin use necessitate therapeutic drug monitoring?
- (2019) Nevio Cimolai INFECTION
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore
- (2019) H. L. Tay et al. Scientific Reports
- Risk prediction for 30-day mortality among patients with Clostridium difficile infections: a retrospective cohort study
- (2019) Hsiu-Yin Chiang et al. Antimicrobial Resistance and Infection Control
- Risk Factors for BI/NAP1/027 Clostridioides difficile Infections and Clinical Outcomes Compared With Non-NAP1 Strains
- (2019) Nandita S Mani et al. Open Forum Infectious Diseases
- Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study
- (2019) Jane Freeman et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions
- (2018) G. Ianiro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients
- (2018) Diana C. Ford et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
- (2018) Dale N Gerding et al. CLINICAL INFECTIOUS DISEASES
- A Randomized, Placebo-Controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile Associated Diarrhea in Adults undergoing Hematopoietic Stem Cell Transplantation
- (2018) Kathleen M Mullane et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study
- (2018) E. Manea et al. CLINICAL MICROBIOLOGY AND INFECTION
- Update of treatment algorithms for Clostridium difficile infection
- (2018) R.E. Ooijevaar et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes
- (2018) M. Falcone et al. CLINICAL MICROBIOLOGY AND INFECTION
- Guidance document for prevention of Clostridium difficile infection in acute healthcare settings
- (2018) S. Tschudin-Sutter et al. CLINICAL MICROBIOLOGY AND INFECTION
- Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics
- (2018) Y.H. van Beurden et al. CLINICAL MICROBIOLOGY AND INFECTION
- The pitfalls of laboratory diagnostics of Clostridium difficile infection
- (2018) M. Krutova et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel
- (2018) Wasef Na’amnih et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clinical outcomes of Clostridium difficile infection according to strain type. A prospective study in medical wards
- (2018) S. Serafino et al. European Journal of Internal Medicine
- Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score
- (2018) Javier Cobo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness
- (2018) Oliver A Cornely et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Acute kidney injury impact on inpatient mortality in Clostridium difficile infection: A national propensity-matched study
- (2018) Paris Charilaou et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Tobacco use as a screener for Clostridium difficile infection outcomes
- (2018) A.K. Barker et al. JOURNAL OF HOSPITAL INFECTION
- Efficacy and safety of fidaxomicin for the treatment of Clostridioides ( Clostridium ) difficile infection in a randomized, double-blind, comparative Phase III study in Japan
- (2018) Hiroshige Mikamo et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial
- (2018) Benoit Guery et al. LANCET INFECTIOUS DISEASES
- Derivation and Validation of a Clostridium difficile Infection Recurrence Prediction Rule in a National Cohort of Veterans
- (2018) Kelly R. Reveles et al. PHARMACOTHERAPY
- An Observational Cohort Study of Clostridium difficile Ribotype 027 and Recurrent Infection
- (2018) Krishna Rao et al. mSphere
- No survival advantage exists for patients undergoing loop ileostomy for clostridium difficile colitis
- (2018) Bradley R. Hall et al. AMERICAN JOURNAL OF SURGERY
- Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT
- (2018) Jotham Suez et al. CELL
- Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients
- (2018) Alex Ganetsky et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
- (2018) Maria J. G. T. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection
- (2018) Audrey S. Kulaylat et al. JAMA Surgery
- Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
- (2018) Miguel Salavert et al. ADVANCES IN THERAPY
- Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study
- (2018) Chris A. Gentry et al. CLINICAL MICROBIOLOGY AND INFECTION
- Toxin B PCR amplification cycle threshold adds little to clinical variables to predict outcomes in Clostridium difficile infection: a retrospective cohort study.
- (2018) Julia Origüen et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial
- (2018) Zhi-Dong Jiang et al. PLoS One
- Is there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)?
- (2017) C. E. Berry et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital
- (2017) Marie Pichenot et al. INFECTION
- Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection
- (2017) Dina Kao et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clostridium difficile PCR Cycle Threshold Predicts Free Toxin
- (2017) Fiona Senchyna et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection
- (2017) M. J. T. Crobach et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile–associated disease
- (2017) Paula Ferrada et al. Journal of Trauma and Acute Care Surgery
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
- (2017) Richard J Vickers et al. LANCET INFECTIOUS DISEASES
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal Calprotectin Level Reflects the Severity ofClostridium difficileInfection
- (2017) Jieun Kim et al. Annals of Laboratory Medicine
- Loop ileostomy versus total colectomy as surgical treatment for Clostridium difficile–associated disease
- (2017) Paula Ferrada et al. Journal of Trauma and Acute Care Surgery
- Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection
- (2017) Raseen Tariq et al. JAMA Internal Medicine
- Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
- (2017) Maureen Watt et al. JOURNAL OF MEDICAL ECONOMICS
- Clostridium difficile fecal toxin level is associated with disease severity and prognosis
- (2017) Nathaniel A Cohen et al. United European Gastroenterology Journal
- Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection
- (2017) Vicente Boix et al. Open Forum Infectious Diseases
- Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains
- (2017) Jieun Kim et al. PLoS One
- Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France
- (2017) Emilie Baro et al. PLoS One
- Hospital-acquired Clostridium difficile infection in Mainland China: A seven-year (2009–2016) retrospective study in a large university hospital
- (2017) Qiaomai Xu et al. Scientific Reports
- Clostridium difficileassociated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients withC. difficileinfection
- (2016) Z. Kassam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections
- (2016) Alex Carignan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clostridium difficile ribotype 176 – A predictor for high mortality and risk of nosocomial spread?
- (2016) Sylvia Polivkova et al. ANAEROBE
- Factors predictive of severe Clostridium difficile infection depend on the definition used
- (2016) Nagham Khanafer et al. ANAEROBE
- Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
- (2016) Colleen R. Kelly et al. ANNALS OF INTERNAL MEDICINE
- The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series
- (2016) Christine M. Akamine et al. BMC INFECTIOUS DISEASES
- Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for RecurrentClostridium difficileInfection: An Open-Label, Randomized Controlled Trial
- (2016) Susy S. Hota et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of Oral Vancomycin in Preventing RecurrentClostridium difficileInfection in Patients Treated With Systemic Antimicrobial Agents: Table 1.
- (2016) Nicholas W. Van Hise et al. CLINICAL INFECTIOUS DISEASES
- Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study
- (2016) B. Gergely Szabo et al. CLINICAL MICROBIOLOGY AND INFECTION
- European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection
- (2016) M.J.T. Crobach et al. CLINICAL MICROBIOLOGY AND INFECTION
- Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population
- (2016) C. ALICINO et al. EPIDEMIOLOGY AND INFECTION
- The effect of statins on the outcome of Clostridium difficile infection in hospitalized patients
- (2016) A. Atamna et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis
- (2016) T. Larrainzar-Coghen et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
- (2016) Maureen Watt et al. INFECTION
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection
- (2016) Christine H. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection
- (2016) Clayton M. Spiceland et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Identification of Factors Impacting Recurrent Clostridium difficile Infection and Development of a Risk Evaluation Tool
- (2016) Bethanne P Carpenter et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Thrombocytopenia in hospitalized patients with severe clostridium difficile infection
- (2016) Eric M. Fountain et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection
- (2016) Lauren Lapointe-Shaw et al. PLoS One
- Growth Patterns of Clostridium difficile – Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study
- (2016) Sarah Tschudin-Sutter et al. PLoS One
- Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrentClostridium difficileinfection
- (2015) G. Cammarota et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Delirium and other clinical factors with Clostridium difficile infection that predict mortality in hospitalized patients
- (2015) Laurie R. Archbald-Pannone et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Appendectomy: a risk factor for colectomy in patients with Clostridium difficile
- (2015) Felix A. Yong et al. AMERICAN JOURNAL OF SURGERY
- The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients WithClostridium difficileInfection
- (2015) Kristina E. E. Rokas et al. CLINICAL INFECTIOUS DISEASES
- Clostridium difficileRibotype 027: Relationship to Age, Detectability of Toxins A or B in Stool With Rapid Testing, Severe Infection, and Mortality
- (2015) Krishna Rao et al. CLINICAL INFECTIOUS DISEASES
- Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes
- (2015) J. Freeman et al. CLINICAL MICROBIOLOGY AND INFECTION
- Role of binary toxin in the outcome of Clostridium difficile infection in a non-027 ribotype setting
- (2015) E. REIGADAS et al. EPIDEMIOLOGY AND INFECTION
- Assessment of Clostridium difficile Burden in Patients Over Time With First Episode Infection Following Fidaxomicin or Vancomycin
- (2015) Seth T. Housman et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Cost-Effectiveness Analysis of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
- (2015) Raghu U. Varier et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection
- (2015) Sahil Khanna et al. Internal and Emergency Medicine
- Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients
- (2015) Mohamed Abdelfatah et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment ofClostridium difficileInfection
- (2015) Natasha N. Pettit et al. PHARMACOTHERAPY
- Continuous Proton Pump Inhibitor Therapy and the Associated Risk of RecurrentClostridium difficileInfection
- (2015) Emily G. McDonald et al. JAMA Internal Medicine
- A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection
- (2015) Xi Na et al. PLoS One
- Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections
- (2014) Kathleen Mullane et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fidaxomicin Therapy in Critically Ill Patients with Clostridium difficile Infection
- (2014) Samuel Penziner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
- (2014) Marya D Zilberberg et al. BMC INFECTIOUS DISEASES
- NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection
- (2014) I. See et al. CLINICAL INFECTIOUS DISEASES
- Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study
- (2014) Ilan Youngster et al. CLINICAL INFECTIOUS DISEASES
- Risk Estimation for Recurrent Clostridium difficile Infection Based on Clinical Factors
- (2014) Ralph B. D'Agostino et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
- (2014) Stuart Johnson et al. CLINICAL INFECTIOUS DISEASES
- Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality
- (2014) J. H. Boone et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clostridium difficile Infection (CDI) Severity and Outcome among Patients Infected with the NAP1/BI/027 Strain in a Non-Epidemic Setting
- (2014) T. Scardina et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus
- (2014) Penny Clohessy et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
- (2014) D. Nathwani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A prospective study of community-associated Clostridium difficile infections: The role of antibiotics and co-infections
- (2014) Surabhi K. Taori et al. JOURNAL OF INFECTION
- Fulminant Clostridium difficile colitis
- (2014) Gwendolyn M. van der Wilden et al. Journal of Trauma and Acute Care Surgery
- Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria
- (2014) Peter Starzengruber et al. WIENER KLINISCHE WOCHENSCHRIFT
- Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients
- (2013) Daniel E Freedberg et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections
- (2013) Christina M Surawicz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Assessing Bias in Studies of Prognostic Factors
- (2013) Jill A. Hayden et al. ANNALS OF INTERNAL MEDICINE
- Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection
- (2013) A. Sarah Walker et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Is colectomy for fulminantClostridium difficilecolitis life saving? A systematic review
- (2013) D. B. Stewart et al. Colorectal Disease
- Impact of ribotype 027 on Clostridium difficile infection in a geriatric department
- (2013) G. Mascart et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Electronic Health Record–Based Detection of Risk Factors for Clostridium difficile Infection Relapse
- (2013) Courtney Hebert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain
- (2013) D. Rodriguez-Pardo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Resolution of Clostridium difficile–Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
- (2013) Oliver A. Cornely et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Age on Treatment Outcomes inClostridium difficileInfection
- (2013) Thomas J. Louie et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Poor Functional Status as a Risk Factor for SevereClostridium difficileInfection in Hospitalized Older Adults
- (2013) Krishna Rao et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery
- (2013) Brian T. Bateman et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial
- (2013) Stephen J Allen et al. LANCET
- Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
- (2013) Timothy D Planche et al. LANCET INFECTIOUS DISEASES
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States
- (2013) Paul M. Stranges et al. VALUE IN HEALTH
- Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease
- (2012) A. N. Ananthakrishnan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clostridium difficile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis
- (2012) Sailajah Janarthanan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice
- (2012) C. A. Warren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Observational Study Comparing Three Different Treatment Regimes in Patients with Clostridium difficile Infection
- (2012) Judith M. Wenisch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clostridium difficile Ribotype Does Not Predict Severe Infection
- (2012) Seth T. Walk et al. CLINICAL INFECTIOUS DISEASES
- Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection
- (2012) M. M. Nerandzic et al. CLINICAL INFECTIOUS DISEASES
- Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
- (2012) I. Figueroa et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials
- (2012) Derrick W. Crook et al. CLINICAL INFECTIOUS DISEASES
- Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
- (2012) D. W. Eyre et al. CLINICAL INFECTIOUS DISEASES
- Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
- (2012) O. A. Cornely et al. CLINICAL INFECTIOUS DISEASES
- Can we identify patients at high risk of recurrent Clostridium difficile infection?
- (2012) C.P. Kelly CLINICAL MICROBIOLOGY AND INFECTION
- Acute Kidney Injury is an Independent Marker of Severity in Clostridium difficile Infection
- (2012) Sahil Khanna et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- PPI Therapy and Albumin are Better Predictors of Recurrent Clostridium difficile Colitis than Choice of Antibiotics
- (2012) Alizah Rotramel et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Lymphopenia as a novel marker of Clostridium difficile infection recurrence
- (2012) Valéry Lavergne et al. JOURNAL OF INFECTION
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
- (2012) Oliver A Cornely et al. LANCET INFECTIOUS DISEASES
- Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study
- (2012) Sahil Khanna et al. MAYO CLINIC PROCEEDINGS
- The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study
- (2011) Sahil Khanna et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Diabetes mellitus as a risk factor for recurrence of Clostridium difficile infection in the acute care hospital setting
- (2011) Rada Shakov et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Antimicrobial Use and Risk for Recurrent Clostridium difficile Infection
- (2011) Dimitri M. Drekonja et al. AMERICAN JOURNAL OF MEDICINE
- Diverting Loop Ileostomy and Colonic Lavage
- (2011) Matthew D. Neal et al. ANNALS OF SURGERY
- Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection
- (2011) Milagros Gonzales et al. BMC INFECTIOUS DISEASES
- Risk Factors Associated With Complications and Mortality in Patients With Clostridium difficile Infection
- (2011) R. H. Morrison et al. CLINICAL INFECTIOUS DISEASES
- A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection
- (2011) K. W. Garey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics
- (2011) Marjolein P. M. Hensgens et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- CSI: a severity index for Clostridium difficile infection at the time of admission
- (2011) O.A. Lungulescu et al. JOURNAL OF HOSPITAL INFECTION
- Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score
- (2011) M.R. Welfare et al. JOURNAL OF HOSPITAL INFECTION
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticoids Are Associated With Increased Risk of Short-Term Mortality in Hospitalized Patients With Clostridium difficile-Associated Disease
- (2010) Rohit Das et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection
- (2010) Jose Cadena et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
- (2010) Amy Linsky ARCHIVES OF INTERNAL MEDICINE
- AGREE II: advancing guideline development, reporting and evaluation in health care
- (2010) M. C. Brouwers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Predictors of Death afterClostridium difficileInfection: A Report on 128 Strain‐Typed Cases from a Teaching Hospital in the United Kingdom
- (2010) Vhairi Wilson et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Clostridium difficile infection in Europe: a hospital-based survey
- (2010) Martijn P Bauer et al. LANCET
- A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin
- (2010) G. W. Tannock et al. MICROBIOLOGY-SGM
- Fulminant Clostridium difficile Colitis
- (2009) Elizabeth A. Sailhamer ARCHIVES OF SURGERY
- Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality
- (2009) Mark Miller et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)
- (2009) M.P. Bauer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Mortality and risk stratification in patients withClostridium difficile-associated diarrhoea
- (2009) S. Bhangu et al. Colorectal Disease
- C. difficile Colitis—Predictors of Fatal Outcome
- (2009) Haig Dudukgian et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Safety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers following Single and Multiple Oral Doses
- (2008) Y. K. Shue et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection
- (2008) T. J. Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary:Decreased Effectiveness of Metronidazole for the Treatment ofClostridium difficileInfection?
- (2008) Ed J. Kuijper et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Clinical and Microbiological Response to Treatment ofClostridium difficile–Associated Disease with Metronidazole and Vancomycin
- (2008) Wafa N. Al‐Nassir et al. CLINICAL INFECTIOUS DISEASES
- Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
- (2008) K.W. Garey et al. JOURNAL OF HOSPITAL INFECTION
- Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
- (2008) Marc GH Besselink et al. LANCET
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started